无功能性胰腺神经内分泌肿瘤的临床诊治分析

李婧; 王琳; 康强; 李越华; 朱红; 陈怡璇; 雷学芬

doi:10.12259/j.issn.2095-610X.S20230706

无功能性胰腺神经内分泌肿瘤的临床诊治分析

doi: 10.12259/j.issn.2095-610X.S20230706

李婧¹,
王琳¹,
康强¹,
李越华¹,
朱红¹,
陈怡璇²,
雷学芬^2, ,

1.
昆明医科大学第二附属医院肝胆胰外科
2.
肿瘤科，云南昆明　650101

基金项目: 国家自然科学基金资助项目（81860423）；云南省科技厅-昆明医科大学应用基础研究联合专项基金面上项目（2019FE001-071）

详细信息

作者简介:
李婧（1994～），女，纳西族，云南大理人，医学硕士，住院医师，主要从事神经内分泌肿瘤的诊治工作

通讯作者:
雷学芬，E-mail ：leixuefen@kmmu.edu.cn

中图分类号: R735.9
计量
- 文章访问数: 2434
- HTML全文浏览量: 1769
- PDF下载量: 16
- 被引次数: 0
出版历程
- 收稿日期: 2023-05-23
- 网络出版日期: 2023-07-17
- 刊出日期: 2023-07-25

Analysis of Clinical Diagnosis and Treatment of Nonfunctional Pancreatic Neuroendocrine Neoplasms

1.
Dept. of Hepatopancreatobiliary Surgery
2.
Dept. of Oncology，The 2nd Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650101，China

摘要

摘要: 目的探讨手术切除对无功能性胰腺神经内分泌肿瘤（nonfunctioning pancreatic neuroendocrine neoplasms，NF-pNENs）患者预后的影响。方法回顾性分析2011年1月至2020年12月就诊于昆明医科大学第二附属医院的45例经术后病理确诊为NF-pNENs患者的临床及随访资料。结果随访时间为6～112个月，中位随访时间47个月，获得随访的患者有43例，术后有1例复发、2例远处转移，存活40例，死亡3例，1例分化良好的G2患者术后83个月因全身多发转移死亡，2例分化差的 G3患者于术后6个月死亡。NF-pNENs患者术后5 a生存率为95.3%。结论手术作为目前唯一能治愈pNENs的手段，在专业的胰腺中心是可行的，术前明确WHO分级和淋巴结是否转移有利于手术方式的选择，术中需要进行规范的淋巴结清扫获得足够数目的淋巴结来明确转移情况，才能更好地指导预后评价。
- 胰腺神经内分泌肿瘤 /
- 手术 /
- 疗效
Abstract: Objective To investigate the prognosis of surgical resection in patients with nonfunctioning pancreatic neuroendocrine neoplasms （NF-pNENs）. Methods The clinical and follow-up data of 45 patients who were pathologically confirmed NF-pNENs in the Second Affiliated Hospital of Kunming Medical University from January 2011 to December 2020 were retrospectively analyzed. Results The follow-up time was 6 to 112 months, and the median follow-up time was 47 months. A total of 43 patients were followed up. Postoperative recurrence occurred in 1 case, distant metastasis in 2 cases, 40 cases survived, and 3 cases died, one well-differentiated G2 patient died 83 months after surgery due to multiple systemic metastasis, and two poorly differentiated G3 patients died 6 months after surgery. The 5-year postoperative survival rate of patients with NF-pNENs was 95.3%. Univariate analysis showed that the tumor WHO grade and lymph node metastasis were related to the prognosis of NF-pNENs patients, and the difference was statistically significant （P < 0.05）. Multivariate analysis did not suggest independent factors affecting the prognosis of NF-pNENs. Conclusions Surgery is the only cure for pNENs currently, which is available in specialized pancreatic centers. Preoperative identification of WHO grade and lymph node metastasis is conducive to the choice of surgical mode. Standard intraoperative lymph node dissection is required to obtain a sufficient number of lymph nodes to clarify the metastasis, so as to better guide the prognostic evaluation.
- Pancreatic neuroendocrine neoplasms /
- Surgery /
- Curative effect

HTML全文

图 1 pNENs CT表现

A：平扫时A胰颈部出现2.5 cm×2.0 cm大小的等密度影；B：增强扫描时动脉期表现为“富血供”肿瘤。

Figure 1. pNENs CT performance

下载: 全尺寸图片幻灯片

图 2 胰体尾+脾切除患者术后46个月出现肝脏多发转移

A：肝脏大小不一的转移灶；B：最大的转移灶位于肝左右叶交界处；C：经肝动脉造影显示肝内多个团块状转移瘤病灶。

Figure 2. Multiple liver metastases were observed 46 months after pancreatococcygeal and splenectomy

下载: 全尺寸图片幻灯片

图 3 45例NF-pNENs患者生存曲线（月）

Figure 3. Survival curves of 45 patients with NF-pNENs （months）

下载: 全尺寸图片幻灯片

参考文献(17)

[1]	吴文铭,陈洁,白春梅,等. 中国胰腺神经内分泌肿瘤诊疗指南(2020)[J]. 协和医学杂志,2021,12(4):460-480.
[2]	Raj N,Reidy-Lagunes D. Systemic therapies for advanced pancreatic neuroendocrine tumors[J]. Hematol Oncol Clin North Am,2016,30(1):119-133. doi: 10.1016/j.hoc.2015.09.005
[3]	Falconi M,Eriksson B,Kaltsas G,et al. ENETS Consensus Guidelines Update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors[J]. Neuroendocrinology,2016,103(2):153-171. doi: 10.1159/000443171
[4]	楼文晖,刘颖斌,梁廷波,等. 胰腺术后外科常见并发症诊治及预防的专家共识(2017)[J]. 协和医学杂志,2017,8(Z1):139-146.
[5]	宗志勇,朱仕超. 术后肺炎预防和控制专家共识[J]. 中华临床感染病杂志,2018,11(1):11-19.
[6]	Zhang I Y,Zhao J,Fernandez-Del Castillo C,et al. Operative versus nonoperative management of nonfunctioning pancreatic neuroendocrine tumors[J]. J Gastrointest Surg,2016,20(2):277-283. doi: 10.1007/s11605-015-3043-5
[7]	王喆,张磊,许雪峰. 胰腺神经内分泌肿瘤生物标记物研究进展[J]. 中国实用外科杂志,2022,42(10):1189-1193.
[8]	Lo G C,Kambadkone A. MR imaging of pancreatic neuroendocrine tumors[J]. Magn Reson Imaging Clin N Am,2018,26(3):391-403. doi: 10.1016/j.mric.2018.03.010
[9]	Yano M,Shetty A S,Williams G A,et al. Qualitative imaging features of pancreatic neuroendocrine neoplasms predict histopathologic characteristics including tumor grade and patient outcome[J]. Abdom Radiol (NY),2022,47(12):3971-3985. doi: 10.1007/s00261-022-03430-7
[10]	张轩豪,孟国梁. 胰腺神经内分泌肿瘤临床诊疗策略解析[J]. 现代医学与健康研究电子杂志,2023,7(1):134-138.
[11]	Lopez-Aguiar A G,Zaidi M Y,Beal E W,et al. Defining the role of lymphadenectomy for pancreatic neuroendocrine tumors: An eight-institution study of 695 patients from the US neuroendocrine tumor study group[J]. Ann Surg Oncol,2019,26(8):2517-2524. doi: 10.1245/s10434-019-07367-y
[12]	Zhang Z,Wang F,Li Z,et al. Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors[J]. BMC Surg,2022,22(1):160. doi: 10.1186/s12893-022-01595-y
[13]	Wang W Q,Zhang W H,Gao H L,et al. A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors[J]. J Gastroenterol,2021,56(4):395-405. doi: 10.1007/s00535-021-01777-0
[14]	Yoshida T,Hijioka S,Hosoda W,et al. Surgery for pancreatic neuroendocrine tumor G3 and carcinoma G3 should be considered separately[J]. Ann Surg Oncol,2019,26(5):1385-1393. doi: 10.1245/s10434-019-07252-8
[15]	Feng T,Lv W,Yuan M,et al. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma[J]. World J Surg Oncol,2019,17(1):54. doi: 10.1186/s12957-019-1597-5
[16]	Perysinakis I,Aggeli C,Kaltsas G,et al. Neoadjuvant therapy for advanced pancreatic neuroendocrine tumors: an emerging treatment modality?[J]. Hormones (Athens),2016,15(1):15-22. doi: 10.1007/BF03401399
[17]	韩序,楼文晖. 胰腺神经内分泌肿瘤的外科决策[J]. 肝胆外科杂志,2021,29(3):168-170.

相关文章(20)

[1]	毛健宇, 陈建军, 阎静楠, 王泉, 詹力, 李石乔, 保文莉. 超声引导下肋间神经脉冲射频治疗胸椎高节段带状疱疹后神经痛的临床疗效, 昆明医科大学学报.
[2]	王燕, 丁荣, 张吕玲, 王若花, 赵晓玲, 马娜. 输血治疗联合放化疗在结直肠癌患者中的疗效及对肿瘤标志物和T淋巴细胞水平的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220809
[3]	陈昌贤, 张丽菊, 姜晓明, 张振勇, 刘为军. 结直肠神经内分泌肿瘤的治疗进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20201242
[4]	赵辉, 纳强, 赵佳. 腰椎退行性侧弯合并多节段腰椎管狭窄的短期手术疗效分析, 昆明医科大学学报.
[5]	罗伟, 王顺军, 方克伟, 陈韬, 陈蓉琼, 王辉涛, 杨博伟, 郭海翔, 张海燕, 李沛, 柯昌兴, 刘建和. 隐匿阴茎改良手术的疗效与安全性观察, 昆明医科大学学报.
[6]	潘子鹏. 腹腔镜阑尾切除术治疗急性阑尾炎的临床疗效及其安全性评价, 昆明医科大学学报.
[7]	马琳. 早期低位直肠癌行经肛局部扩大全层切除术对疗效及预后的影响, 昆明医科大学学报.
[8]	李晓凯. 腹腔镜保留脾脏的胰体尾切除术8例手术体会, 昆明医科大学学报.
[9]	张美琼. 剖宫产手术孕妇不同镇痛方式的镇痛效果观察, 昆明医科大学学报.
[10]	陈永生. 脱套式阴茎固定术治疗肥胖引起的阴茎外观不满意80例疗效观察, 昆明医科大学学报.
[11]	武学才. 手术治疗椎管内良性肿瘤23例的临床观察, 昆明医科大学学报.
[12]	孙恒. 改进的义眼台植入手术方法临床疗效观察, 昆明医科大学学报.
[13]	杨文举. 角膜缘干细胞移植术治疗翼状胬肉临床疗效观察, 昆明医科大学学报.
[14]	刘礼杉. 徒手心肺复苏与心肺复苏机在呼吸心跳骤停患者CPR救治中的疗效比较, 昆明医科大学学报.
[15]	甘志明. 肥胖对直肠/肛管恶性肿瘤患者行结肛吻合术后近期疗效的影响, 昆明医科大学学报.
[16]	朱丽仙. 双侧髂内动脉栓塞术和结扎术对产后大出血的临床疗效比较, 昆明医科大学学报.
[17]	陆晓涛. 老年股骨粗隆间骨折不同内固定手术疗效分析, 昆明医科大学学报.
[18]	付桂兵. Ponseti方法与肌力平衡术治疗先天性马蹄内翻足疗效分析, 昆明医科大学学报.
[19]	苏松. 颅内大型脑膜瘤的显微手术疗效观察, 昆明医科大学学报.
[20]	. 高血压脑出血合并糖尿病的术式选择及围手术期处理, 昆明医科大学学报.